Here’s Your Perfect Nighttime Routine, Based On Your Zodiac Sign
As an especially eclectic and avant-garde sign, Aquarius, you’re known for your creative endeavors. You’re also…
As an especially eclectic and avant-garde sign, Aquarius, you’re known for your creative endeavors. You’re also…
Safety-focused large language model company Hippocratic AI has been issued its first patent by the U.S….
Several healthcare leaders are showing their support for the Biden-Harris Administration’s new proposed rule that would…
Elon Musk’s brain-computer interface implant startup Neuralink announced on X that it received approval to launch…
This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news…
This is the 22nd and final episode of the MedCity Moves podcast. Moving forward, Senior Reporter…
Cofactor AI, a company that helps hospitals appeal claims denials, announced it raised $4 million in…
Practice Better, a practice management platform for health and wellness practitioners, announced it raised $13 million…
Health systems across the country are scaling hybrid and home-based care models by integrating virtual visits…
Researchers from South Korea have built machine learning-based models that can predict mood episodes using only…
Highly anticipated Phase 2 data for Amgen’s obesity drug show that on average, participants lost about…
If you’ve ever wondered why you feel fine(ish) during the day but then are suddenly drowning…
With the Well+Good SHOP, our editors put their years of know-how to work in order to…
Google has introduced Health AI Developer Foundations (HAI-DEF), a public resource for healthcare developers that provides…
Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and…
The Health Resources and Services Administration (HRSA) announced last week a $52 million investment in 54…
GE HealthCare unveiled Pristina Via, a mammography system aimed at enhancing the screening experience for technologists…
Roche, already partnered with Poseida Therapeutics in the development of off-the-shelf cell therapies for blood cancers,…